Literature DB >> 26447790

Selection of Ideal Candidates for Surgical Salvage of Head and Neck Squamous Cell Carcinoma: Effect of the Charlson-Age Comorbidity Index and Oncologic Characteristics on 1-Year Survival and Hospital Course.

JeeHong Kim1, Seungwon Kim2, William G Albergotti2, Phillip A Choi1, Daniel James Kaplan1, Shira Abberbock3, Jonas T Johnson2, Neil Gildener-Leapman4.   

Abstract

IMPORTANCE: Salvage surgery for recurrent head and neck squamous cell carcinoma (HNSCC) carries substantial risks of morbidity and mortality. Risk factors for death within 1 year should be better defined.
OBJECTIVES: To report preoperative oncologic prognostic factors predictive of short-term (<1 year) survival after salvage surgery in patients with HNSCC, to assess whether preoperative age and comorbidity predicts 1-year mortality, and to report hospital courses after salvage surgery within 1 year. DESIGN, SETTING, AND PARTICIPANTS: A retrospective medical record review of 191 patients with recurrent HNSCC treated with salvage surgery from January 1, 2003, through December 31, 2013, at a tertiary academic center.
INTERVENTIONS: Surgical salvage of HNSCC (larynx, oral cavity, oropharynx, or hypopharynx) with curative intent. MAIN OUTCOMES AND MEASURES: Primary outcome was survival 1 year after salvage surgery. Secondary outcomes were length of inpatient hospital stay, days of admissions, and skilled nursing facility disposition within 1 year stratified by survival status. Presalvage Charlson-Age Comorbidity Index (CACI) was calculated. Associations among CACI, oncologic risk factors, and risk of death within 1 year after salvage surgery are investigated using multivariable analysis.
RESULTS: Of 191 patients studied, 53 (27.7%) died within 1 year after salvage surgery. Patients who died within 1 year had more total inpatient admissions (P < .001), longer total length of stay (P < .001), and higher risk of discharge to a skilled nursing facility (P < .001) and spent 17.3% (interquartile range, 5.2-36.3) of their remaining days in the hospital. Independent risk factors for death within 1 year are CACI (relative risk [RR], 1.43; 95% CI, 1.16-1.76), primary T3 or T4 stage (RR, 2.34; 95% CI, 1.27-4.31), and disease-free interval of less than 6 months (RR, 5.61; 95% CI, 1.78-16.7). CONCLUSIONS AND RELEVANCE: Medical comorbidity and age as measured by the CACI, primary T3 or T4 stage, and short disease-free interval must be considered in selecting patients ideal for surgical salvage surgery for recurrent HNSCC. Patients with these risk factors should be more strongly considered for palliative measures.

Entities:  

Mesh:

Year:  2015        PMID: 26447790      PMCID: PMC4884653          DOI: 10.1001/jamaoto.2015.2158

Source DB:  PubMed          Journal:  JAMA Otolaryngol Head Neck Surg        ISSN: 2168-6181            Impact factor:   6.223


  20 in total

1.  Comorbidity as a major risk factor for mortality and complications in head and neck surgery.

Authors:  Marciano B Ferrier; Emiel B Spuesens; Saskia Le Cessie; Robert J Baatenburg de Jong
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2005-01

Review 2.  Comorbidity in patients with cancer of the head and neck: prevalence and impact on treatment and prognosis.

Authors:  Jay F Piccirillo; Anna Vlahiotis
Journal:  Curr Oncol Rep       Date:  2006-03       Impact factor: 5.075

Review 3.  Decision making in the management of recurrent head and neck cancer.

Authors:  Allen S Ho; Dennis H Kraus; Ian Ganly; Nancy Y Lee; Jatin P Shah; Luc G T Morris
Journal:  Head Neck       Date:  2013-03-08       Impact factor: 3.147

4.  The intensity and variation of surgical care at the end of life: a retrospective cohort study.

Authors:  Alvin C Kwok; Marcus E Semel; Stuart R Lipsitz; Angela M Bader; Amber E Barnato; Atul A Gawande; Ashish K Jha
Journal:  Lancet       Date:  2011-10-05       Impact factor: 79.321

Review 5.  Head and neck squamous cell carcinoma in the young: a spectrum or a distinct group? Part 2.

Authors:  M Toner; E M O'Regan
Journal:  Head Neck Pathol       Date:  2009-08-21

6.  Salvage treatment for recurrent squamous cell carcinoma of the oral cavity.

Authors:  G J Schwartz; R H Mehta; B L Wenig; C Shaligram; L G Portugal
Journal:  Head Neck       Date:  2000-01       Impact factor: 3.147

Review 7.  Comorbidity and survival after early breast cancer. A review.

Authors:  Lotte Holm Land; Susanne Oksbjerg Dalton; Trine Lembrecht Jørgensen; Marianne Ewertz
Journal:  Crit Rev Oncol Hematol       Date:  2011-05-04       Impact factor: 6.312

8.  Recurrence and salvage treatment of squamous cell carcinoma of the oral cavity.

Authors:  Bon Seok Koo; Young Chang Lim; Jin Seok Lee; Eun Chang Choi
Journal:  Oral Oncol       Date:  2006-02-07       Impact factor: 5.337

9.  Age as a prognostic factor for complications of major head and neck surgery.

Authors:  Marina Boruk; Boris Chernobilsky; Richard M Rosenfeld; Gady Har-El
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2005-07

10.  The role of salvage surgery in patients with recurrent squamous cell carcinoma of the oropharynx.

Authors:  Mark E Zafereo; Matthew M Hanasono; David I Rosenthal; Erich M Sturgis; Jan S Lewin; Diana B Roberts; Randal S Weber
Journal:  Cancer       Date:  2009-12-15       Impact factor: 6.860

View more
  18 in total

1.  Neck recurrence in clinically node-negative oral cancer: 27-year experience at a single institution.

Authors:  Aviram Mizrachi; Jocelyn C Migliacci; Pablo H Montero; Sean McBride; Jatin P Shah; Snehal G Patel; Ian Ganly
Journal:  Oral Oncol       Date:  2018-02-20       Impact factor: 5.337

2.  High-risk pathological features at the time of salvage surgery predict poor survival after definitive therapy in patients with head and neck squamous cell carcinoma.

Authors:  Sulsal Haque; Vidhya Karivedu; Muhammed K Riaz; David Choi; Logan Roof; Sarah Z Hassan; Zheng Zhu; Roman Jandarov; Vinita Takiar; Alice Tang; Trisha Wise-Draper
Journal:  Oral Oncol       Date:  2018-11-16       Impact factor: 5.337

3.  Assessing Risk of Severe Complications after Endoscopic Transnasal Transsphenoidal Surgery: A Comparison of Frailty, American Society of Anesthesiologists, and Comorbidity Scores.

Authors:  Jordan M Sukys; Roy Jiang; Richard P Manes
Journal:  J Neurol Surg B Skull Base       Date:  2021-12-16

4.  Resection and reconstruction of the carotid artery for head and neck squamous cell carcinoma: a GETTEC study.

Authors:  Yonjae Kim; Pierre Philouze; Olivier Malard; Xavier Dufour; Lara Nokovitch; Philippe Céruse; Philippe Zrounba; Charles Maquet; Sophie Deneuve
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-03-31       Impact factor: 3.236

5.  Management of recurrent head and neck cancer: variables related to salvage surgery.

Authors:  Laura Gañán; Montserrat López; Jacinto García; Eduard Esteller; Miquel Quer; Xavier León
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-05-17       Impact factor: 2.503

6.  Predictors of survival in patients undergoing oropharyngeal surgery for cancer recurrence after radiation therapy.

Authors:  Molly E Heft Neal; Julia Brennan; Catherine T Haring; J Chad Brenner; Francis Worden; Paul Swiecicki; Michelle Mierzwa; Keith A Casper; Kelly M Malloy; Chaz L Stucken; Scott A McLean; Mark E Prince; Carol R Bradford; Gregory T Wolf; Andrew G Shuman; Steven B Chinn; Douglas B Chepeha; Andrew J Rosko; Matthew E Spector
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-03-19       Impact factor: 2.503

7.  Accuracy of co-morbidity data in patients undergoing abdominal wall hernia repair: a retrospective study.

Authors:  S Hajibandeh; S Hajibandeh; R Deering; D McEleney; J Guirguis; S Dix; A Sreh; E Toner; A El Muntasar; A Kausar; G Sheikh; D OShea; A Shafiq; A Kelly; A Khan; D Arumugam; A Evans
Journal:  Hernia       Date:  2017-12-14       Impact factor: 4.739

8.  Correlation between the duration of locoregional control and survival in T1-T2 oropharyngeal cancer patients.

Authors:  Alexandre Caula; Marc Boukhris; Joanne Guerlain; Yungan Tao; Ingrid Breuskin; Haitham Mirghani; Stéphane Temam; Philippe Gorphe
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-01-21       Impact factor: 2.503

9.  Salvage surgery improves the treatment outcome of patients with residual/recurrent maxillary sinus cancer after superselective intra-arterial cisplatin infusion with concomitant radiation therapy.

Authors:  Nayuta Tsushima; Satoshi Kano; Takayoshi Suzuki; Hiroshi Idogawa; Daisuke Yoshida; Koichi Yasuda; Manami Otsuka; Hidefumi Aoyama; Akihiro Homma
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-04-18       Impact factor: 2.503

10.  Salvage surgery for patients with residual/persistent diseases after improper or insufficient treatment of oral squamous cell carcinoma: can we rectify these mistakes?

Authors:  Yue He; Zhonglong Liu; Surui Sheng; Weijin Gao; Xiao Tang; Xiaoguang Li; Chunyue Ma
Journal:  BMC Cancer       Date:  2021-07-31       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.